S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:PETS

PetMed Express - PETS Stock Forecast, Price & News

$16.56
-0.15 (-0.90%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.28
$16.69
50-Day Range
$16.41
$22.22
52-Week Range
$16.00
$29.53
Volume
406,935 shs
Average Volume
451,693 shs
Market Capitalization
$349.08 million
P/E Ratio
29.05
Dividend Yield
7.25%
Price Target
$18.00

PetMed Express MarketRank™ Forecast

Analyst Rating
Reduce
1.00 Rating Score
Upside/​Downside
2.7% Upside
$17.00 Price Target
Short Interest
Bearish
19.92% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.18mentions of PetMed Express in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
92.31%
From $0.39 to $0.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Retail/Wholesale Sector

184th out of 209 stocks

Drug Stores & Proprietary Stores Industry

4th out of 5 stocks


PETS stock logo

About PetMed Express (NASDAQ:PETS) Stock

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
What Does Pet Insurance Cover?
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Why PetMed Express Was a Dog of a Stock This Week
PetMed Express: Short Puts Make Much More Sense
PetMed Express Q3 2023 Earnings Preview
Earnings Preview: PetMed Express
PETS PetMed Express, Inc.
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Company Calendar

Last Earnings
10/24/2021
Ex-Dividend for 2/27 Dividend
2/16/2023
Dividend Payable
2/27/2023
Today
3/24/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
5/08/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
219
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$17.00
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+7.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$21.10 million
Pretax Margin
5.78%

Debt

Sales & Book Value

Annual Sales
$273.42 million
Cash Flow
$1.13 per share
Book Value
$6.78 per share

Miscellaneous

Free Float
20,220,000
Market Cap
$352.25 million
Optionable
Optionable
Beta
0.68

Social Links


Key Executives

  • Matthew N. Hulett
    President, Chief Executive Officer & Director
  • Christine Chambers
    Chief Financial Officer
  • Mark Moseley
    Chief Technology & Information Officer
  • Carolyn Carden
    Vice President-Product Management
  • Eddie Khoriaty
    Dir-Pharmacy Services & Prescription Dept. Manager













PETS Stock - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" PETS shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2023?

1 brokers have issued 1 year target prices for PetMed Express' shares. Their PETS share price forecasts range from $17.00 to $17.00. On average, they anticipate the company's stock price to reach $17.00 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2023?

PetMed Express' stock was trading at $17.70 on January 1st, 2023. Since then, PETS shares have decreased by 5.6% and is now trading at $16.71.
View the best growth stocks for 2023 here
.

Are investors shorting PetMed Express?

PetMed Express saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 4,200,000 shares, a decline of 13.2% from the February 13th total of 4,840,000 shares. Based on an average trading volume of 380,300 shares, the short-interest ratio is presently 11.0 days.
View PetMed Express' Short Interest
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our PETS earnings forecast
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings results on Sunday, October, 24th. The company reported $0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by $0.03. The company earned $67.39 million during the quarter, compared to analysts' expectations of $70.90 million. PetMed Express had a trailing twelve-month return on equity of 8.54% and a net margin of 4.38%. During the same quarter last year, the firm posted $0.42 earnings per share.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, February 6th. Investors of record on Monday, February 20th will be given a dividend of $0.30 per share on Monday, February 27th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.18%. The ex-dividend date of this dividend is Thursday, February 16th.
Read our dividend analysis for PETS
.

Is PetMed Express a good dividend stock?

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 6.91%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 210.53%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 160.00% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (4.43%), Charles Schwab Investment Management Inc. (2.96%), ProShare Advisors LLC (2.83%), Mirae Asset Global Investments Co. Ltd. (2.80%), Dimensional Fund Advisors LP (2.77%) and Geode Capital Management LLC (2.05%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $16.71.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $352.25 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.57 on an earnings per share basis.

How many employees does PetMed Express have?

The company employs 219 workers across the globe.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 3/24/2023 by MarketBeat.com Staff